Amgen Reports Q2 Beat, Provides Guidance
By Investing.com Staff Amgen (NASDAQ:AMGN) reported its {{erl-6466||Q2 results, with EPS of $4.65 coming in better than the consensus estimate of $4.39. Revenue grew 1% year-over-year to...
-
-
Amgen Tops Q2 EPS by 26c, Offers Guidance
Amgen (NASDAQ:AMGN) reported Q2 EPS of $4.65, $0.26 better than the analyst estimate of $4.39. Revenue for the quarter came in at $6.59 billion versus the consensus estimate of $6.53...
-
Amgen Earnings, Revenue beat In Q2
Investing.com - Amgen (NASDAQ:AMGN) reported on Thursday second quarter {{erl-6466||earnings that beat analysts' forecasts and revenue that topped expectations. Amgen announced earnings...
-
Amgen to Acquire ChemoCentryx in $3.7bn Deal
By Sam Boughedda Amgen (NASDAQ:AMGN) is set to acquire ChemoCentryx (NASDAQ:CCXI) for $52 per share in cash, it was announced Thursday, representing an enterprise value of approximately $3.7...
-
Amgen adds potential blockbuster drug with $3.7 billion ChemoCentryx deal
By Manas Mishra (Reuters) -U.S. drugmaker Amgen Inc is buying ChemoCentryx Inc for $3.7 billion to gain access to a potential blockbuster treatment for inflammatory disorders.
-
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AstraZeneca/Merck's Lynparza Scores European Approval In Early Breast Cancer The European...
-
Amgen to gain rare-disease drug in $3.7 billion acquisition of ChemoCentryx
Shares of ChemoCentryx Inc. soared 109.0% in premarket trading on Thursday after Amgen Inc. announced plans to buy the company for $3.7 billion in cash. The deal will give Amgen access to...
-
Amgen, IRS in a Row over $10.7B Tax Bill. How will AMGN Stock Price be Affected?
The Wall Street Journal (WSJ) reports that Amgen (AMGN) is in trouble over its low tax rate of 12.5% compared to the industry average of 18% in the last decade. While the low tax burden is...
-
Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report
Amgen Inc (NASDAQ: AMGN) will fight Internal Revenue Service over the company’s international tax strategy and $10.7 billion in back taxes and penalties, Wall Street Journal reported. The...
-
Dow Futures Ease Following Best Week Since 2020
By Oliver Gray Investing.com - Dow futures were trading slightly lower during Sunday’s evening deals, after major benchmark indices finished this week significantly higher and...
-
Amgen’s Lumakras combination data held for August lung cancer meeting
By Deena Beasley (Reuters) – Trial data on Amgen Inc’s Lumakras will be released later on Tuesday by the World Conference on Lung Cancer (WCLC), but meeting organizers decided to hold...
-
Friday’s Top Analyst Upgrades and Downgrades: Amgen, CarMax, GE, Home Depot, Marathon Digital, MetLife, Palantir, Realty Income, WeWork and More
Friday's top analyst upgrades and downgrades included Amgen, CarMax, D.R. Horton, Frontier, General Electric, Home Depot, Ingersoll Rand, Marathon Digital, MetLife, Palantir Technologies,...
-
Friday’s Top Analyst Upgrades and Downgrades: Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, FedEx, S&P Global, Unity Software, Warner Bros. Discovery
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information Services, FedEx,...
-
Amgen drug extends survival in some inoperable colon cancers
By Nancy Lapid (Reuters) – The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.33%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 3.57%
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Consumer Services, Consumer Goods and Technology sectors propelled shares lower. At the close in NYSE,...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.47%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Oil & Gas and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.99%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Oil & Gas, Technology and Basic Materials sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 3.12%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Technology, Consumer Services and Consumer Goods sectors propelled shares lower. At the close in NYSE,...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.85%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Oil & Gas and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
-
Pre-Open Stock Movers 04/28: Facebook, ServiceNow, and Qualcomm Gain on Earnings; Teladoc Tumbles (more...)
Pre-Open Stock Movers:Teladoc (NYSE:TDOC) 44% LOWER; reported Q1 EPS of ($41.58), which may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million...
-
Billion in IRS Back Taxes Overshadows Amgen's Solid Q1
Amgen (NASDAQ:AMGN) shares dropped over 5% after-hours, despite the company’s reported strong Q1 results, after disclosing that the IRS is seeking $7.1 billion in back taxes and penalties...
-
After-Hours Stock Movers 04/27: Facebook Surges on Earnings; Teladoc, Align Fall After Results (more...)
After-Hours Stock Movers:Teladoc (NYSE:TDOC) 38% LOWER; reported Q1 EPS of ($41.58), which may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4...
-
Amgen Tops Q1 EPS by 15c, Offers Guidance
Amgen (NASDAQ:AMGN) reported Q1 EPS of $4.25, $0.15 better than the analyst estimate of $4.10. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07...
-
Amgen Earnings, Revenue beat In Q1
Investing.com - Amgen (NASDAQ:AMGN) reported on Wednesday first quarter {{erl-6466||earnings that beat analysts' forecasts and revenue that topped expectations. Amgen announced earnings...
-
Russia Gas Supplies, Big Tech Divergence, Home Sales - What's Moving Markets
By Geoffrey Smith Investing.com -- Microsoft and Alphabet have differing fortunes in the first quarter, as TikTok takes a bigger bite out of YouTube's advertising revenue. The earnings...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 2.38%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Consumer Goods, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.56%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Financials, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 2.37%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Consumer Services, Technology and Financials sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.29%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Technology, Consumer Services and Consumer Goods sectors propelled shares lower. At the close in NYSE,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average unchanged
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Telecoms, Utilities and Oil & Gas sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.47%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Utilities, Technology and Industrials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.86%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Technology, Basic Materials and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow...
-
Dow Futures Rise 190 Pts; Strong Corporate Earnings Boost Sentiment
By Peter Nurse Investing.com - U.S. stocks are seen opening higher Wednesday, boosted by generally strong quarterly corporate earnings ahead of key consumer inflation data. At 7:15 AM ET...
-
Wall Street ends higher; bank stocks rise with Treasury yields
By Noel Randewich and Bansari Mayur Kamdar (Reuters) - Wall Street ended sharply higher on Tuesday, lifted by Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT), while a jump in Treasury...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
